This research study is studying a possible therapy as a possible treatment for the
consequences of Multiple Myeloma with renal insufficiency.
This research study is a Phase II clinical trial. This study will assess the safety and
tolerability of denosumab in Multiple Myeloma participants, by studying drug interactions
with different parts of the body.
The FDA (the U.S. Food and Drug Administration) has not approved Denosumab for this specific
disease but it has been approved denosumab for use in other cancers to treat cancer-related
bone disease such as prostate and breast cancer.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.